Peptinov has set-up a unique proprietary discovery platform for the identification of immunotherapies targeting self-proteins.

Peptinov is thus able to rapidly identify candidate immunotherapies able to induce the production of neutralizing antibodies. This platform is applicable to any type of protein.

Peptinov is able to provide discovery services to industrial partners for the conception, design and development of peptide immunogens, spanning large therapeutic areas.